Structural requirements for competitive alpha-adrenoceptor occupancy by cyclic and opened analogues of WB 4101.
D000818:Animals; D001667:Binding, Competitive; D004146:Dioxanes / Q000378:metabolism* / Q000494:pharmacology; D004147:Dioxins / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism*; D014649:Vas Deferens / Q000378:metabolism
D004146:Dioxanes; D004147:Dioxins; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; C010654:(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane; D009638:Norepinephrine